Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma.
Matsumoto K, Noda T, Kobayashi S, Sakano Y, Yokota Y, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Gotoh K, Takeda Y, Tanemura M, Umeshita K, Doki Y, Eguchi H.
Matsumoto K, et al. Among authors: tomimaru y.
Cancer Lett. 2021 Mar 1;500:29-40. doi: 10.1016/j.canlet.2020.12.011. Epub 2020 Dec 8.
Cancer Lett. 2021.
PMID: 33307155